Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia And New Zealand On Track For Joint Drug Agency And A Single Point Of Entry For Pharma

This article was originally published in PharmAsia News

Executive Summary

Ongoing efforts to create a single regulator for medicines and therapeutic products in Australia and New Zealand got a boost last week when the two governments jointly announced plans to create a new agency within five yeas

You may also be interested in...



Australia and New Zealand Take First Steps To Joint Approval System For Drugs

OTC drugs the first area for Trans-Tasman agreement between Australia and New Zealand proposed joint approval system.

Australia, New Zealand Consider Regulatory Reforms; PHARMAC To Add Sanofi Diabetes Agent Daonil: Australia, New Zealand Regulatory Roundup

PERTH, Australia - Australia's Therapeutic Goods Association announced it plans to implement a number of regulatory reforms that aim to update and streamline the existing framework for OTC and Rx products and medical devices

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

SC078343

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel